Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia (RECOVER)
Multi-center, Single-arm, Prospective Study of Transorb™ Self-Gripping REsorbable Mesh in High-risk subjeCts Undergoing Open Repair of VEntral heRnia
Sponsor: Medtronic - MITG
Listed as NCT06449378, this NA trial focuses on Hernia and Hernia Abdominal Wall and remains ongoing. Sponsored by Medtronic - MITG, it has been updated 8 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2025 — Aug 2025 [monthly]
Recruiting NA
-
Mar 2025 — Jul 2025 [monthly]
Recruiting NA
-
Dec 2024 — Mar 2025 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Nov 2024 — Dec 2024 [monthly]
Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic - MITG
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Cleveland, United States , Colombes, France , Columbus, United States , Evanston, United States , Leuven, Belgium , Lexington, United States , Lille, France , Lyon, France , Newport News, United States , Reims, France and 3 more locations